Unmixed Adalimumab Biosimilar from Japan
Adalimumab biosimilar is a TNF inhibitor monoclonal antibody for rheumatoid arthritis. Supplied unmixed in bulk, it meets HTS 3002.13.00 for immunological products.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Provide biosimilarity study summaries; ensure chain-of-custody for cold storage; avoid pre-filled syringes to stay unmixed